405 related articles for article (PubMed ID: 20237505)
1. Wilms' tumor gene 1 protein represses the expression of the tumor suppressor interferon regulatory factor 8 in human hematopoietic progenitors and in leukemic cells.
Vidovic K; Svensson E; Nilsson B; Thuresson B; Olofsson T; Lennartsson A; Gullberg U
Leukemia; 2010 May; 24(5):992-1000. PubMed ID: 20237505
[TBL] [Abstract][Full Text] [Related]
2. The hematopoietic tumor suppressor interferon regulatory factor 8 (IRF8) is upregulated by the antimetabolite cytarabine in leukemic cells involving the zinc finger protein ZNF224, acting as a cofactor of the Wilms' tumor gene 1 (WT1) protein.
Montano G; Ullmark T; Jernmark-Nilsson H; Sodaro G; Drott K; Costanzo P; Vidovic K; Gullberg U
Leuk Res; 2016 Jan; 40():60-7. PubMed ID: 26563595
[TBL] [Abstract][Full Text] [Related]
3. Presence of Wilms' tumor gene (wt1) transcripts and the WT1 nuclear protein in the majority of human acute leukemias.
Menssen HD; Renkl HJ; Rodeck U; Maurer J; Notter M; Schwartz S; Reinhardt R; Thiel E
Leukemia; 1995 Jun; 9(6):1060-7. PubMed ID: 7596170
[TBL] [Abstract][Full Text] [Related]
4. Leukemia associated mutant Wilms' tumor gene 1 protein promotes expansion of human hematopoietic progenitor cells.
Vidovic K; Ullmark T; Rosberg B; Lennartsson A; Olofsson T; Nilsson B; Gullberg U
Leuk Res; 2013 Oct; 37(10):1341-9. PubMed ID: 23871158
[TBL] [Abstract][Full Text] [Related]
5. The Wilms' tumor suppressor Wt1 activates transcription of the erythropoietin receptor in hematopoietic progenitor cells.
Kirschner KM; Hagen P; Hussels CS; Ballmaier M; Scholz H; Dame C
FASEB J; 2008 Aug; 22(8):2690-701. PubMed ID: 18424770
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.
Zaia A; Fraizer GC; Piantanelli L; Saunders GF
Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720
[TBL] [Abstract][Full Text] [Related]
7. Cyclin A1 regulates WT1 expression in acute myeloid leukemia cells.
Krug U; Yasmeen A; Beger C; Bäumer N; Dugas M; Berdel WE; Müller-Tidow C
Int J Oncol; 2009 Jan; 34(1):129-36. PubMed ID: 19082485
[TBL] [Abstract][Full Text] [Related]
8. Expression of the Wilms' tumor gene (WT1) in normal hemopoiesis.
Baird PN; Simmons PJ
Exp Hematol; 1997 Apr; 25(4):312-20. PubMed ID: 9131006
[TBL] [Abstract][Full Text] [Related]
9. The Wilms' tumor suppressor WT1 enhances CD95L expression and promotes activation-induced cell death in leukemic T cells.
Bourkoula K; Englert C; Giaisi M; Köhler R; Krammer PH; Li-Weber M
Int J Cancer; 2014 Jan; 134(2):291-300. PubMed ID: 23832418
[TBL] [Abstract][Full Text] [Related]
10. The Wilms' tumor gene is expressed in a subset of CD34+ progenitors and downregulated early in the course of differentiation in vitro.
Maurer U; Brieger J; Weidmann E; Mitrou PS; Hoelzer D; Bergmann L
Exp Hematol; 1997 Aug; 25(9):945-50. PubMed ID: 9257807
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of interferon regulatory factor 4 gene expression in leukemic cells due to hypermethylation of CpG motifs in the promoter region.
Ortmann CA; Burchert A; Hölzle K; Nitsche A; Wittig B; Neubauer A; Schmidt M
Nucleic Acids Res; 2005; 33(21):6895-905. PubMed ID: 16396836
[TBL] [Abstract][Full Text] [Related]
12. The Wilms' tumor gene WT1-GFP knock-in mouse reveals the dynamic regulation of WT1 expression in normal and leukemic hematopoiesis.
Hosen N; Shirakata T; Nishida S; Yanagihara M; Tsuboi A; Kawakami M; Oji Y; Oka Y; Okabe M; Tan B; Sugiyama H; Weissman IL
Leukemia; 2007 Aug; 21(8):1783-91. PubMed ID: 17525726
[TBL] [Abstract][Full Text] [Related]
13. Protein tyrosine phosphatase receptor type {gamma} is a functional tumor suppressor gene specifically downregulated in chronic myeloid leukemia.
Della Peruta M; Martinelli G; Moratti E; Pintani D; Vezzalini M; Mafficini A; Grafone T; Iacobucci I; Soverini S; Murineddu M; Vinante F; Tecchio C; Piras G; Gabbas A; Monne M; Sorio C
Cancer Res; 2010 Nov; 70(21):8896-906. PubMed ID: 20959494
[TBL] [Abstract][Full Text] [Related]
14. WT1-mediated repression of the proapoptotic transcription factor ZNF224 is triggered by the BCR-ABL oncogene.
Montano G; Vidovic K; Palladino C; Cesaro E; Sodaro G; Quintarelli C; De Angelis B; Errichiello S; Pane F; Izzo P; Grosso M; Gullberg U; Costanzo P
Oncotarget; 2015 Sep; 6(29):28223-37. PubMed ID: 26320177
[TBL] [Abstract][Full Text] [Related]
15. WT1 and BCR-ABL specific small interfering RNA have additive effects in the induction of apoptosis in leukemic cells.
Elmaagacli AH; Koldehoff M; Peceny R; Klein-Hitpass L; Ottinger H; Beelen DW; Opalka B
Haematologica; 2005 Mar; 90(3):326-34. PubMed ID: 15749664
[TBL] [Abstract][Full Text] [Related]
16. The zinc finger domain of Wilms' tumor 1 suppressor gene (WT1) behaves as a dominant negative, leading to abrogation of WT1 oncogenic potential in breast cancer cells.
Han Y; San-Marina S; Yang L; Khoury H; Minden MD
Breast Cancer Res; 2007; 9(4):R43. PubMed ID: 17634147
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of c-MYC in WT1-mutant tumors: assessment of WT1 putative transcriptional targets using cDNA microarray expression profiling of genetically defined Wilms' tumors.
Udtha M; Lee SJ; Alam R; Coombes K; Huff V
Oncogene; 2003 Jun; 22(24):3821-6. PubMed ID: 12802290
[TBL] [Abstract][Full Text] [Related]
18. Gene expression analysis of BCR/ABL1-dependent transcriptional response reveals enrichment for genes involved in negative feedback regulation.
Håkansson P; Nilsson B; Andersson A; Lassen C; Gullberg U; Fioretos T
Genes Chromosomes Cancer; 2008 Apr; 47(4):267-75. PubMed ID: 18181176
[TBL] [Abstract][Full Text] [Related]
19. The Wilms' tumor gene product represses the transcription of thrombospondin 1 in response to overexpression of c-Jun.
Dejong V; Degeorges A; Filleur S; Ait-Si-Ali S; Mettouchi A; Bornstein P; Binétruy B; Cabon F
Oncogene; 1999 May; 18(20):3143-51. PubMed ID: 10340386
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic disruption of interferon-gamma response through silencing the tumor suppressor interferon regulatory factor 8 in nasopharyngeal, esophageal and multiple other carcinomas.
Lee KY; Geng H; Ng KM; Yu J; van Hasselt A; Cao Y; Zeng YX; Wong AH; Wang X; Ying J; Srivastava G; Lung ML; Wang LD; Kwok TT; Levi BZ; Chan AT; Sung JJ; Tao Q
Oncogene; 2008 Sep; 27(39):5267-76. PubMed ID: 18469857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]